These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17998413)

  • 1. Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene.
    Rottmann S; Speckgens S; Lüscher-Firzlaff J; Lüscher B
    FASEB J; 2008 Apr; 22(4):1124-34. PubMed ID: 17998413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
    Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
    Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation.
    Gehring S; Rottmann S; Menkel AR; Mertsching J; Krippner-Heidenreich A; Lüscher B
    J Biol Chem; 2000 Apr; 275(14):10413-20. PubMed ID: 10744730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.
    Cerni C; Skrzypek B; Popov N; Sasgary S; Schmidt G; Larsson LG; Lüscher B; Henriksson M
    Oncogene; 2002 Jan; 21(3):447-59. PubMed ID: 11821957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling.
    Terragni J; Nayak G; Banerjee S; Medrano JL; Graham JR; Brennan JF; Sepulveda S; Cooper GM
    J Biol Chem; 2011 Oct; 286(42):36215-27. PubMed ID: 21873430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mad side of the Max network: antagonizing the function of Myc and more.
    Rottmann S; Lüscher B
    Curr Top Microbiol Immunol; 2006; 302():63-122. PubMed ID: 16620026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
    Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.
    Foley KP; Eisenman RN
    Biochim Biophys Acta; 1999 May; 1423(3):M37-47. PubMed ID: 10382539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mad1 is a transcriptional repressor of Bcl-6.
    Lee SC; Bottaro A; Chen L; Insel RA
    Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism.
    Palian BM; Rohira AD; Johnson SA; He L; Zheng N; Dubeau L; Stiles BL; Johnson DL
    PLoS Genet; 2014 Dec; 10(12):e1004789. PubMed ID: 25502566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway.
    Kim JH; Lee G; Cho YL; Kim CK; Han S; Lee H; Choi JS; Choe J; Won MH; Kwon YG; Ha KS; Kim YM
    Eur J Pharmacol; 2009 Jan; 602(2-3):422-31. PubMed ID: 19027002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.